BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21820051)

  • 1. A novel application of α-glucosyl hesperidin for nanoparticle formation of active pharmaceutical ingredients by dry grinding.
    Tozuka Y; Imono M; Uchiyama H; Takeuchi H
    Eur J Pharm Biopharm; 2011 Nov; 79(3):559-65. PubMed ID: 21820051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of dissolution and absorption properties of poorly water-soluble drug by preparing spray-dried powders with alpha-glucosyl hesperidin.
    Uchiyama H; Tozuka Y; Imono M; Takeuchi H
    Int J Pharm; 2010 Jun; 392(1-2):101-6. PubMed ID: 20307634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):96-109. PubMed ID: 20674291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglycosylated stevia and hesperidin as pharmaceutical excipients: dramatic improvement in drug dissolution and bioavailability.
    Uchiyama H; Tozuka Y; Imono M; Takeuchi H
    Eur J Pharm Biopharm; 2010 Oct; 76(2):238-44. PubMed ID: 20637868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
    Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
    Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
    Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
    Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
    Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
    Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR investigation of a novel excipient, α-glucosylhesperidin, as a suitable solubilizing agent for poorly water-soluble drugs.
    Zhang J; Tozuka Y; Uchiyama H; Higashi K; Moribe K; Takeuchi H; Yamamoto K
    J Pharm Sci; 2011 Oct; 100(10):4421-31. PubMed ID: 21604275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of dissolution property of poorly water-soluble drug by novel dry coating method using planetary ball mill.
    Sonoda R; Horibe M; Oshima T; Iwasaki T; Watano S
    Chem Pharm Bull (Tokyo); 2008 Sep; 56(9):1243-7. PubMed ID: 18758094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique.
    Chauhan B; Shimpi S; Paradkar A
    Eur J Pharm Sci; 2005 Oct; 26(2):219-30. PubMed ID: 16087324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches.
    Salazar J; Ghanem A; Müller RH; Möschwitzer JP
    Eur J Pharm Biopharm; 2012 May; 81(1):82-90. PubMed ID: 22233547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Glucosyl hesperidin induced an improvement in the bioavailability of pranlukast hemihydrate using high-pressure homogenization.
    Uchiyama H; Tozuka Y; Asamoto F; Takeuchi H
    Int J Pharm; 2011 May; 410(1-2):114-7. PubMed ID: 21419200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ultra-cryo milling and co-grinding technique in liquid nitrogen to produce dissolution-enhanced nanoparticles for poorly water-soluble drugs.
    Sugimoto S; Niwa T; Nakanishi Y; Danjo K
    Chem Pharm Bull (Tokyo); 2012; 60(3):325-33. PubMed ID: 22382412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved anti-diabetic activity of glibenclamide using oral self nano emulsifying powder.
    Bari A; Chella N; Sanka K; Shastri NR; Diwan PV
    J Microencapsul; 2015; 32(1):54-60. PubMed ID: 25090596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling.
    Al-Hamidi H; Edwards AA; Douroumis D; Asare-Addo K; Nayebi AM; Reyhani-Rad S; Mahmoudi J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Mar; 103():189-99. PubMed ID: 23201737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.